Imiloxan hydrochloride, 10mg and 2 more items

The University of Virginia awarded contract A207_PO-0478396 to Medchemexpress LLC on September 9, 2026, for the procurement of pharmaceutical research compounds. The contract, valued at $906, encompasses the delivery of three distinct chemical products to Mark Beenhakker at the University of Virginia. The awarded items include Imiloxan hydrochloride (10 milligrams) at $270, BAY-6096 (5 milligrams) at $520, and Centhaquin (10 milligrams) at $116, each in single bag quantities.

Medchemexpress LLC serves as the prime contractor for this Virginia-based procurement. The contract represents a straightforward materials acquisition supporting the University of Virginia's research operations. While the contract documentation does not specify an explicit performance period beyond the award date, the transaction is structured as a purchase order mechanism typical of institutional research supply procurement. The modest contract value and discrete line item structure indicate this is a routine materials purchase rather than a comprehensive service delivery engagement.